This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Metabolic, endocrine and nutritional disorders
  • /
  • Treatment-naive Gaucher disease patients achieve t...

Treatment-naive Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trials.

Read time: 1 mins
Published:1st Feb 2018
Author: Zimran A, Elstein D, Gonzalez DE, Lukina EA, Qin Y, Dinh Q et al.
Availability: Free full text
Ref.:Blood Cells Mol Dis. 2018;68:153-159.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest